Sousa Cláudia, Rigueiro-Neves Mariana, Miranda Telma, Alegria Paulo, Vale José, Passos Ana Margarida, Langdon Dawn, Sá Maria José
MS Clinic, Department of Neurology, Centro Hospitalar São João Porto, Alameda Prof. Hernâni Monteiro, 4200 - 319, Porto, Portugal.
BRU-IUL, Instituto Universitário de Lisboa (ISCTE-IUL), Lisbon, Portugal.
BMC Neurol. 2018 Oct 17;18(1):172. doi: 10.1186/s12883-018-1175-4.
The validation of international cognitive batteries in different multiple sclerosis (MS) populations is essential. Our objective was to obtain normative data for the Portuguese population of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and assess its reliability.
The BICAMS was applied to 105 MS patients and 60 age, gender and education matched healthy controls (HC). In order to test its reliability, BICAMS was re-administered in a subset of 25 patients after a 7-month interval.
Most participants were women, with a mean age of 37, 21 years and a mean of 14,08 years of education. The vast majority of the MS patients (92.4%) had the relapsing remitting type, 58.1% were professionally active, mean disease duration was 6.52 years, median EDSS score was 1.5 (range: 0-6.0) and the median MSSS score was 2.01 (IQR range: 3.83). The MS group presented significantly higher scores of anxiety and depression than HC and 47,4% had fatigue. The MS group performed significantly worse than the control group across the three neuropsychological tests, yielding the following values: SDMT: t(165) = 3.77, p = .000; CVLT-II: t(165) = 2.98, p = .003; and BVMT-R: t(165) = 2.94, p = .004. The mean raw scores for Portuguese normative data were as follows: SDMT: 58.68 ± 10.02; CVLT-II: 60.47 ± 10.12; and BVMT-R: 24.68 ± 5.52. Finally, test-retest reliability coefficients for each test were as follows: SDMT: r = .90; CVLT-II: r = .71; and BVMT-R: r = .84.
The Portuguese version of BICAMS here in described is a reliable monitoring instrument for identifying MS patients with cognitive impairment.
在不同的多发性硬化症(MS)人群中验证国际认知测试组合至关重要。我们的目标是获取葡萄牙人群的多发性硬化症简易国际认知评估量表(BICAMS)的常模数据并评估其可靠性。
对105例MS患者和60名年龄、性别及教育程度相匹配的健康对照者(HC)进行BICAMS测试。为测试其可靠性,在25例患者间隔7个月后重新进行BICAMS测试。
大多数参与者为女性,平均年龄37.21岁,平均受教育年限14.08年。绝大多数MS患者(92.4%)为复发缓解型,58.1%有职业活动,平均病程6.52年,EDSS评分中位数为1.5(范围:0 - 6.0),MSSS评分中位数为2.01(IQR范围:3.83)。MS组的焦虑和抑郁得分显著高于HC组,47.4%有疲劳症状。在三项神经心理学测试中,MS组的表现显著差于对照组,结果如下:符号数字模态测试(SDMT):t(165) = 3.77,p = .000;加利福尼亚语言学习测验第二版(CVLT-II):t(165) = 2.98,p = .003;本顿视觉保持测验修订版(BVMT-R):t(165) = 2.94,p = .004。葡萄牙常模数据的平均原始分数如下:SDMT:58.68 ± 10.02;CVLT-II:60.47 ± 10.12;BVMT-R:24.68 ± 5.52。最后,每项测试的重测信度系数如下:SDMT:r = .90;CVLT-II:r = .71;BVMT-R:r = .84。
本文所述的葡萄牙语版BICAMS是一种用于识别有认知障碍的MS患者的可靠监测工具。